Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis

Breast Cancer ◽  
2021 ◽  
Author(s):  
Yan Lin ◽  
Ying Xu ◽  
Changjun Wang ◽  
Yu Song ◽  
Xin Huang ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-10 ◽  
Author(s):  
Huimin Jin ◽  
Yuying Xiang ◽  
Yuqian Feng ◽  
Yiting Zhang ◽  
Shan Liu ◽  
...  

Objective. To evaluate the effectiveness and safety of acupuncture moxibustion therapy (AMT) for the breast cancer-related lymphedema (BCRL). Methods. Four English databases (MEDLINE, PubMed, Embase, and Cochrane CENTRAL) and four Chinese databases were searched from their inception to Feb 1, 2020. Eligible randomized controlled trials (RCTs) investigating AMT against any type of controlled intervention in patients for BCRL and assessing clinically relevant outcomes (total effective rate, circumference difference, and Karnofsky performance score) were included. The methodological quality of all selected trials was estimated in accordance with the guidelines published by the Cochrane Collaboration. Review Manager 5.3 was used to conduct analyses. Results. Twelve eligible RCTs are confirmed. Most of the trials selected are regarded as low methodological quality. Compared with Western medicine, physiotherapy, and functional training, traditional AMT has significantly higher treatment effect (RR 1.03 (95% CI: 1.22, 1.45); p<0.00001). In comparison with physiotherapy, AMT is better in reducing edema symptoms (MD = −0.77; 95% CI (−1.13–0.41); p<0.00001). Moreover, pooled results demonstrate that AMT results in better outcomes than functional training and Western medicine in improving Karnofsky performance score of BCRL patients (SMD = 0.69; 95% CI (0.38–1.00); p<0.00001). Conclusion. This systematic review and meta-analysis provides evidence that AMT is serviceable and safe in treating BCRL. With the limited number of available studies and methodology drawbacks, further high-quality RCTs with reasonable designs are still warranted.


2017 ◽  
Vol 162 (2) ◽  
pp. 217-217
Author(s):  
Simona F. Shaitelman ◽  
Yi-Ju Chiang ◽  
Kate D. Griffin ◽  
Sarah M. De Snyder ◽  
Benjamin D. Smith ◽  
...  

2019 ◽  
Vol 45 (12) ◽  
pp. 2307-2317 ◽  
Author(s):  
Wenzhen Hou ◽  
Lixia Pei ◽  
Yafang Song ◽  
Jian Wu ◽  
Hao Geng ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. 153473542110441
Author(s):  
Yu Gao ◽  
Tingting Ma ◽  
Mei Han ◽  
Mingwei Yu ◽  
Xiuhui Wang ◽  
...  

Objective: The aim of this systematic review and meta-analysis of randomized controlled trials (RCTs) was to evaluate the effects of acupuncture and moxibustion (AM) in women with breast cancer-related lymphedema (BCRL). Methods: We retrieved RCTs published before January 24, 2021, from the MEDLINE, EMBASE, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Chongqing VIP (VIP), and Wanfang databases. RCTs that compared acupuncture and/or moxibustion intervention with other treatments were included. A random effects or fixed effects model was used based on the heterogeneity findings. Study quality was evaluated using the Cochrane risk of bias tool. Results: We included 14 RCTs in the analyses, of which 4 RCTs adopted acupuncture, 4 RCTs used moxibustion, and the rest used both. AM significantly reduced arm circumference at the elbow crease compared to routine care (Mean deviation (MD) = −7.26, 95% confidence interval (CI) = −8.30 to −6.21, P < .00001). There was a significant difference between AM and diosmin tablets in the effective index for upper limb lymphedema (MD = 24.68, 95% CI = 24.82-30.53, P < .00001), the range of motion of the shoulder during protraction (MD = 6.77, 95% CI = 2.81-10.73, P = .0008), and adduction (MD = 4.17, 95% CI = 1.02-7.32, P = .01). There was a significant difference between moxibustion and pneumatic circulation (MD = −0.51, 95% CI = −0.85 to −0.17, P = .003) in the visual analog score (VAS) for swelling. Finally, compared to the blank control, acupuncture reduced the VAS for pain (MD = −1.33, 95% CI = −1.52 to −1.15, P < .00001; heterogeneity ( I2) = 0%, P = .57). Conclusion: Our results suggest that AM is effective in the treatment of BCRL. AM may reduce arm circumference at the elbow crease (compared to routine care), increase effective index for upper limb lymphedema (compared to oral diosmin tablets), improve the range of motion of the shoulder during protraction and adduction (compared to oral diosmin tablets), and decrease the VAS for both swelling (compared to pneumatic circulation) and pain (compared to blank control).


2020 ◽  
Vol 28 (8) ◽  
pp. 3593-3603 ◽  
Author(s):  
Timothy Hasenoehrl ◽  
Stefano Palma ◽  
Dariga Ramazanova ◽  
Heinz Kölbl ◽  
Thomas E. Dorner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document